AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.31%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 26.00K | 22.00K | 21.00K | 26.00K | 25.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.00K | 22.00K | 21.00K | 26.00K | 25.00K |
| Cost of Revenue | 5.00K | 4.00K | 40.00K | 68.00K | 10.00K |
| Gross Profit | 21.00K | 18.00K | -19.00K | -42.00K | 15.00K |
| SG&A Expenses | 2.95M | 1.86M | 1.93M | 1.80M | 1.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.54M | 2.25M | 2.97M | 2.47M | 2.67M |
| Operating Income | -3.51M | -2.23M | -2.95M | -2.45M | -2.65M |
| Income Before Tax | -3.79M | -3.02M | -4.18M | -3.28M | -2.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.79M | -3.02M | -4.18M | -3.28M | -2.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.79M | -3.02M | -4.18M | -3.28M | -2.79M |
| EBIT | -3.51M | -2.23M | -2.95M | -2.45M | -2.65M |
| EBITDA | -2.99M | -2.18M | -2.91M | -2.39M | -2.33M |
| EPS Basic | -0.22 | -0.69 | -1.45 | -1.57 | -3.68 |
| Normalized Basic EPS | -0.14 | -0.43 | -0.90 | -1.89 | -2.29 |
| EPS Diluted | -0.22 | -0.69 | -1.45 | -1.57 | -3.68 |
| Normalized Diluted EPS | -0.14 | -0.43 | -0.90 | -1.89 | -2.29 |
| Average Basic Shares Outstanding | 17.12M | 4.35M | 2.88M | 2.10M | 759.30K |
| Average Diluted Shares Outstanding | 17.12M | 4.35M | 2.88M | 2.10M | 759.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |